1/Here’s an excellent Financial Times article which accurately describes the problematic situation which many big Pharma companies such as $PFE $JNJ $BMY $ABBV $LLY $MRK $SNY and others are now facing - the upcoming patent cliff scenario. With IP rights which are about to expire in 2027-2028, big Pharma companies face a huge pressure on both their pipeline and their future revenue streams and here is how they intend to address this burning issue. $XBI 🧵👇